Alto Neuroscience Analyst Price Targets - Benzinga

SPY757.12+0.19%QQQ692.74+0.33%BTC/USD78,019.40+0.75%DIA517.65+0.10%GLD356.15+0.10%TLT81.65−0.23%

Premium Services

Alto Neuroscience Inc

ANRONYSE

Trade with Public

Trade with Public

$22.60

-0.87-3.71%

Last update: Oct 30, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Alto Neuroscience Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alto Neuroscience (ANRO).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$31Upside to Avg. PT+35.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$55→$60
Aug 17, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$50→$55
Aug 13, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$24→$26
Aug 13, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$28→$37
May 18, 2026	Baird	Brian Skorney	PT Cut	Outperform	$38→$36
May 14, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$21→$24
May 11, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Apr 22, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Apr 2, 2026	Baird	Brian Skorney	PT Cut	Outperform	$41→$38
Apr 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Apr 2, 2026	Jones Trading	Justin Walsh	PT Cut	Buy	$49→$44
Apr 2, 2026	Wedbush	Laura Chico	PT Cut	Neutral	$22→$21
Apr 2, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Mar 18, 2026	Baird	Brian Skorney	PT Raise	Outperform	$22→$41
Mar 17, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Mar 17, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$13→$22
Feb 17, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$27→$28
Jan 5, 2026	Chardan Capital	Keay Nakae	PT Raise	Buy	$15→$30
Nov 17, 2025	BTIG	Thomas Shrader	Initiate	Buy	$27
Nov 13, 2025	Baird	Brian Skorney	PT Raise	Outperform	$16→$22

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $55 to $60.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $55

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $50 to $55.

Benzinga Newsdesk

PRO
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $24 to $26.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $37

BTIG analyst Thomas Shrader maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $28 to $37.

Benzinga Newsdesk

PRO
Baird Maintains Outperform on Alto Neuroscience, Lowers Price Target to $36

Baird analyst Brian Skorney maintains Alto Neuroscience (NYSE:ANRO) with a Outperform and lowers the price target from $38 to $36.

Benzinga Newsdesk

PRO
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $24

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $21 to $24.

Benzinga Newsdesk